Fibrinolysis inhibitors in plaque stability: a morphological association of PAI-1 and TAFI in advanced carotid plaque.

about

Fibrinolysis inhibitors in plaque stability: a morphological association of PAI-1 and TAFI in advanced carotid plaque.

Item

http://www.wikidata.org/entity/Q48636985

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Fibrinolysis inhibitors in pla ...... FI in advanced carotid plaque.

@en

Fibrinolysis inhibitors in pla ...... FI in advanced carotid plaque.

@nl

type

Item

label

Fibrinolysis inhibitors in pla ...... FI in advanced carotid plaque.

@en

Fibrinolysis inhibitors in pla ...... FI in advanced carotid plaque.

@nl

prefLabel

Fibrinolysis inhibitors in pla ...... FI in advanced carotid plaque.

@en

Fibrinolysis inhibitors in pla ...... FI in advanced carotid plaque.

@nl

P1476

Fibrinolysis inhibitors in pla ...... FI in advanced carotid plaque.

@en

P2093

A Lindgren

http://www.w3.org/2001/XMLSchema#string

A-C Jönsson Rylander

http://www.w3.org/2001/XMLSchema#string

G Böttcher

http://www.w3.org/2001/XMLSchema#string

I Kalies

http://www.w3.org/2001/XMLSchema#string

J Deinum

http://www.w3.org/2001/XMLSchema#string

K Wåhlander

http://www.w3.org/2001/XMLSchema#string

P2860

Rab3D and annexin A2 play a role in regulated secretion of vWF, but not tPA, from endothelial cells

The role of pericytes in blood-vessel formation and maintenance

Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators

Colocalization of thrombin, PAI-1, and vitronectin in the atherosclerotic vessel wall: A potential regulatory mechanism of thrombin activity by PAI-1/vitronectin complexes

Platelets retain high levels of active plasminogen activator inhibitor 1

Natural history and histological classification of atherosclerotic lesions: an update.

Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditions

Controls for immunohistochemistry: the Histochemical Society's standards of practice for validation of immunohistochemical assays.

Update on acute coronary syndromes: the pathologists' view.

Plasma Biomarkers of Inflammation, Endothelial Function and Hemostasis in Cerebral Small Vessel Disease.

P304

758-769

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JTH.13641

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Göran Bergström

P577

2017-01-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28135035

http://www.w3.org/2001/XMLSchema#string